Articles from Watchmaker Genomics

Watchmaker Genomics, a leader in high-performance genomics solutions, today announced an important milestone in providing comprehensive and robust automated solutions for next-generation sequencing (NGS) workflows. Its collaboration with Revvity has resulted in fully automated and verified methods for all of its DNA and RNA library preparation kits on the Sciclone™ G3 NGSx* liquid handling workstation – making Revvity the first provider to automate Watchmaker’s entire library preparation portfolio.

Watchmaker Genomics, a leading provider of precision tools for genomic research and clinical applications, today announced the successful completion of a key milestone under its TAPS (TET-assisted pyridine borane sequencing) Technology License and Supply Alliance1 with Exact Sciences. This progress underscores Watchmaker’s commitment to commercializing TAPS, a transformative epigenetic analysis technology for high-accuracy genomic DNA methylation analysis, and accelerates efforts to bring TAPS-powered products to market, with early access programs launching soon and full commercial availability anticipated later in 2025.

Inocras, a leading innovator in whole genome sequencing and bioinformatics, and Watchmaker Genomics, an expert in genomic tool development for demanding sequencing applications, are thrilled to announce an expansion of their partnership to deliver solutions aimed at accelerating insights for patients and researchers.

Watchmaker Genomics, a provider of innovative solutions for molecular analysis, announced the launch of a high-purity RNase Inhibitor that is well-suited for a wide range of applications where maintaining RNA integrity is critical, including single-cell and single-nuclei sequencing, as well as pathogen detection.

Watchmaker Genomics, a supplier of innovative products for molecular analysis, announced the launch of the Watchmaker mRNA Library Prep Kit – designed to streamline and accelerate mRNA library preparation, offering both speed and sensitivity to the genomics community.

Watchmaker Genomics, a supplier of innovative products for molecular analysis, today announced a multi-year, co-exclusive agreement with Exact Sciences Corporation, a leading provider of cancer screening and diagnostic tests, to develop and commercialize the breakthrough DNA methylation analysis technology, TET-assisted pyridine borane sequencing (TAPS). Watchmaker will apply its expertise in engineering DNA-modifying enzymes to further improve the TAPS chemistry, ultimately enabling advanced applications, including cancer screening and minimal residual disease (MRD) testing. Under the licensing agreement, Watchmaker may develop and commercialize the TAPS technology under its own brand.